IP Library Granted Patent US 12,623,992
Granted Patent B2
US 12,623,992 · App. 17/680,362 · Granted May 12, 2026

Key intermediate for synthesis of prostaglandin compound and preparation method thereof

Inventors: Xiaobing Ding (Hangzhou, CN); Qiwei Lang (Hangzhou, CN); Wei Su (Hangzhou, CN); Shuang Gao (Hangzhou, CN)
Assignee: SHENZHEN CATALYS TECHNOLOGY CO., LTD
C07C59/48C07C33/025C07C33/20C07C43/23C07C49/757C07C59/46C07D307/935C07D317/12C07F7/1804C07C2601/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,623,992
App. No.
17/680,362
Granted
May 12, 2026
Kind
B2
Abstract

The present invention relates to the technical field of organic chemical engineering, and in particular to a key intermediate for synthesizing prostaglandin compounds and a preparation method therefor. When applied to the synthesis of prostaglandin compounds, the process flow is simplified, the yield and product purity are improved, the production costs are reduced, and the industrial application is easy.

Claims (26)

1 . A key intermediate for synthesis of a prostaglandin compound, having a structure shown below:

wherein denotes a single bond or double bond, and if it is a double bond, R 1 is absent; and wherein R 1 and R 2 are each H or protecting groups; R 3 and R 4 are the same or different alkyl or aryl, or R 3 and R 4 form a ring.

2 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , having a structure shown below:

wherein R 1 , R 2 , R 3 , and R 4 are as defined above.

3 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , which is

wherein R 1 , R 2 , R 3 , and R 4 are as defined above.

4 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , which is

wherein R 1 and R 2 are as defined above, and n is an integer from 1 to 3.

5 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , wherein the intermediate is

6 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , wherein the protecting group is selected from an ether protecting group, an acyl protecting group, a silyl ether protecting group, an acetal protecting group.

7 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , wherein the intermediate is selected from:

8 . A method for preparing the key intermediate for the synthesis of the prostaglandin compound according to claim 1 , comprising steps of:

a) asymmetrically reducing compound S1 to obtain chiral alcohol compound S2, and then protecting hydroxyl group of the chiral alcohol compound S2 with silane to obtain Weinreb amide compound S3;

b) subjecting the Weinreb amide compound S3 to an addition reaction with an alkyne reagent to obtain enyne compound S4;

c) subjecting the enyne compound S4 to a Zhang enyne cycloisomerization to obtain five-membered ring S5;

d) conjugating the five-membered ring S5 to reduce double bond thereof to obtain compound S6, and further reducing ketone of the compound S6 to obtain compound S7; and

e) deprotecting the compound S7 by removing TIPS thereof to obtain compound S8;

referring to the following reaction route:

9 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , having a structure shown below:

wherein R 1 , R 2 , R 3 , and R 4 are as defined above.

10 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , which is

wherein R 1 , R 2 , R 3 , and R 4 are as defined above.

11 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , which is

wherein R 1 and R 2 are as defined above, and n is an integer from 1 to 3.

12 . The key intermediate for the synthesis of the prostaglandin compound according to claim 1 , wherein the intermediate is selected from:

wherein P is a protecting group.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2022
From: DING, XIAOBING; LANG, QIWEI; SU, WEI; GAO, SHUANG
To: SHENZHEN CATALYS TECHNOLOGY CO., LTD
Reel/Frame 059097/0359 →
Priority Claims (1)
CN 202010978194.8 · Sep 16, 2020 · national
Continuity (2)
Continuation PCTCN2021117634 · Sep 10, 2021
Related Publication 20220281797A1 · Sep 8, 2022
References Cited (6)
US 5599837A · Kishi et al. · 1997 [cited by applicant]
Zhang, Fuhao et al. “Concise, scalable and enantioselective total synthesis of prostaglandins.” Nature Chemistry. vol. 13 (Jul. 2021), pp. 692-697. (Year: 2021). [cited by examiner]
American Chemical Society. Chemical Abstract Service. RN 2649250-97-3. Entered into STN: Jun. 30, 2021. (Year: 2021). [cited by examiner]
American Chemical Society. Chemical Abstract Service. RN 37752-08-2. Entered into STN: Nov. 16, 1984. (Year: 1984). [cited by examiner]
Josef Fried et al. Stereospecific Total Synthesis of the Natural and Racemic Prostaglandins of the E and F Series «Journal of the American Chemical Society» Jun. 14, 1972 (Jun. 14, 1972) No. 12 vol. 94 ISSN: 0002-7863 p… [cited by applicant]
Taehyeong Kim et al. Total synthesis of PGF2α and 6,15-diketo-PGF1α and formal synthesis of 6-keto-PGF1α via three-component coupling «Tetrahedron» Sep. 10, 2019 (Sep. 10, 2019) No. 42 vol. 75 ISSN:0040-4020 p. 130593 (… [cited by applicant]